By Abigail Klein Leichman December 18, 2014
ISRAEL21c rounds up the top super-cool technological advances from Israeli companies that you should keep an eye on next year.
[The wearable and mobile health devices] global trend will keep gathering steam in 2015. Israeli-made face- and eye-tracking sensors could be embedded in smart watches and other wearables to measure sobriety and diagnose conditions ranging from ADHD to concussion to Alzheimer’s. Israeli knowhow will be packaged into more and more mobile devices that double as diagnostic, monitoring and treatment tools.
Companies to watch: Umoove face- and eye-tracking software for mobile devices; Oxitone wearable pulse oximetry platform; MobileOCT, software to turn a smartphone into a diagnostic tool for detecting cervical cancer; MeMed Diagnostics, a novel assay that accurately distinguishes between bacterial and viral infections.
Read full article here.
Changing the World through Tech:
MobileOCT celebrated in this year’s Nominet Trust 100
● Annual Nominet Trust 100 (NT100) list of inspiring digital social innovations highlights impact of global ‘tech for good’ market
● Technology’s transformative power is driving social change around the world
● Using smartphones to detect cancer
London, UK, 4 December 2014: Today, Nominet Trust proudly announced that MobileOCT has been named among the 2014 Nominet Trust 100 (NT100) - a global list of 100 inspiring ventures Projects featured on the list are using technology to tackle some of the world’s biggest social problems from education and human rights abuses to climate change and health.
Following a global call for nominations earlier this year MobileOCT, headquartered in Tel Aviv, Israel, has been selected by an independent steering committee in recognition of it’s game-changing efforts to transform smartphones into tools for reducing cervical cancer, the number one cause of death for women in low-resource settings.
Commenting on their inclusion in the NT100, Ariel Beery, CEO, MobileOCT, "it's an honor being recognized alongside such transformative companies. It's amazing being part of a global initiative to apply technology for social good."
This year, MobileOCT is rubbing shoulders with organisations from established tech markets in the US and Europe, such as Freecycle, Random Hacks of Kindness and Google's self-driving car, alongside initiatives from emerging economies, including eCompliance, a revolutionary use of fingertip-readers to record tuberculosis treatment in India; philanthropic food-photo sharing app Feedie from South Africa and HarassMap, an anonymous crowd-mapping platform for sexual harassment in Egypt.
Annika Small, CEO of Nominet Trust, the UK’s leading tech for good funder, said: “There is a striking progression in the quality and maturity of this year’s NT100, indicative of a wider evolution in the tech for social good’ sector as a whole.
“More people than ever before are using technology to solve problems that matter to them in bold new ways. This year’s NT100 list is populated by extraordinary people with inspirational stories to tell and it shows us that imagination, social conscience and technology make a potent mix to affect change.
The final list was compiled by an illustrious steering group chaired by Annika Small and including General Partner of Google Ventures, Tom Hulme; angel investor and entrepreneur, Sherry Coutu; Chief Executive of Big Lottery Fund, Dawn Austwick; CEO of Big Society Capital, Nick O’Donohue; Director of Wayra Europe, Simon Devonshire; innovation expert, Charles Leadbeater; internet entrepreneur, Dickie Armour; Senior Fellow at the Stanford University Center for Philanthropy and Civil Society, Lucy Bernholz; and Deputy Editor of The FT Weekend Magazine, Alice Fishburn.
To see the full list of NT100 projects, please visit the Social Tech Guide, a dynamic, growing online resource to help inspire social enterprises, or follow the action @socialtechguide / #2014NT100.
By Zach Davidson, Chloe Pinto, Dr. David Levitz
Cervical cancer prevention remains a top medical priority for much of the developing world. In order to minimise the gap in screening, availability between the developed and the developing worlds, visual inspection with acetic acid (or VIA) was proposed as a cheap, relatively efficient and easy to implement screening method for low-income settings. As a result, in many developing countries, VIA is the primary step, and the standard, for cervical cancer screening; however, it is rarely corroborated by colposcopy and biopsy. Despite its success, VIA presents a major challenge: with a positive predictive value (PPV) of 17% , five out of six patients receive cryotherapy unnecessarily, as a result of a false positive VIA result. In order to reduce the number of false positives, MobileOCT has developed a mobile colposcope that serves as an adjunct to VIA, while also providing a technological platform that enables high-end multi-modal imaging.